To say everything is 100% perfect would be inaccurate. However, we are in much better shape than we had thought we might be,” ...

Lower pharmacy school enrollment and insurance reimbursements have created challenges for Missouri pharmacies. Total intern ...

The concern has been that PBMs may have the incentive to prefer higher-cost drugs since they can negotiate larger rebates on them.The Federal Trade Commission in September sued the largest PBMs – CVS ...

The Health Care Benefits segment includes Aetna and other health insurance businesses. CVS acquired Aetna in 2017. In 2023, ...

(Image Credits: Pixabay) Zydus Lifesciences Ltd on Tuesday announced that it has entered into an agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR tablets used in treatment of ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.

The major holdouts were the two largest PBMs besides CVS Caremark: UnitedHealth-owned Optum Rx and Cigna-owned Express Scripts, according to CVS CFO Tom Cowhey. However, it’s normal for ...

CVS Caremark will add Zydus' Zituvio and combination products to its template formulary starting January 1, 2025, Zydus Lifesciences Ltd said in a regulatory filing. Template formulary is a ...

Zydus Lifesciences share price advanced over 5 percent in trade today after the company announced an agreement with US healthcare firm CVS Caremark to add its diabetes combination products to its ...